Liquid biopsy: A new avenue in pathology

被引：30
作者：
Ghosh, Ratan Kumar [1 ]
Pandey, Tushar [2 ]
Dey, Pranab [3 ]
机构：
[1] Post Grad Inst Med Educ & Res, Dept Nephrol, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Dept Pathol, Chandigarh, India
[3] Post Grad Inst Med Educ & Res, Dept Cytol & Gynaec Pathol, Chandigarh, India
来源：
CYTOPATHOLOGY | 2019年 / 30卷 / 02期
关键词：
cell-free DNA; exosome; liquid biopsy; technology; CIRCULATING TUMOR-CELLS; PLASMA; DNA; EXOSOMES; BIOMARKERS; SERUM; BRAF;
D O I：
10.1111/cyt.12661
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Liquid biopsy is a relatively new entity. This non-invasive technique provides real-time information about a tumour. The liquid biopsy contains circulating tumour cells, cell-free DNA and exosomes. The main indications for liquid biopsy include early diagnosis, screening, detection of minimal residual disease, designing personalised treatment and predicting biological behaviour of the tumour. In this review, we discuss various aspects of liquid biopsy and compare it with conventional biopsy.
引用
收藏
页码：138 / 143
页数：6
相关论文
共 31 条
[21]   Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor-Positive Breast Cancer [J].
Paoletti, Costanza ;
Muniz, Maria C. ;
Thomas, Dafydd G. ;
Griffith, Kent A. ;
Kidwell, Kelley M. ;
Tokudome, Nahomi ;
Brown, Martha E. ;
Aung, Kimberly ;
Miller, M. Craig ;
Blossom, Dorothy L. ;
Schott, Anne F. ;
Henry, N. Lynn ;
Rae, James M. ;
Connelly, Mark C. ;
Chianese, David A. ;
Hayes, Daniel F. .
CLINICAL CANCER RESEARCH, 2015, 21 (11) :2487-2498
[22]   Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients [J].
Rack, Brigitte ;
Schindlbeck, Christian ;
Jueckstock, Julia ;
Andergassen, Ulrich ;
Hepp, Philip ;
Zwingers, Thomas ;
Friedl, Thomas W. P. ;
Lorenz, Ralf ;
Tesch, Hans ;
Fasching, Peter A. ;
Fehm, Tanja ;
Schneeweiss, Andreas ;
Lichtenegger, Werner ;
Beckmann, Matthias W. ;
Friese, Klaus ;
Pantel, Klaus ;
Janni, Wolfgang .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (05)
[23]   Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing [J].
Roberts, Brian S. ;
Hardigan, Andrew A. ;
Moore, Dianna E. ;
Ramaker, Ryne C. ;
Jones, Angela L. ;
Fitz-Gerald, Meredith B. ;
Cooper, Gregory M. ;
Wilcox, C. Mel ;
Kimberly, Robert P. ;
Myers, Richard M. .
CLINICAL CANCER RESEARCH, 2018, 24 (09) :2092-2099
[24]   Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level [J].
Sakaizawa, K. ;
Goto, Y. ;
Kiniwa, Y. ;
Uchiyama, A. ;
Harada, K. ;
Shimada, S. ;
Saida, T. ;
Ferrone, S. ;
Takata, M. ;
Uhara, H. ;
Okuyama, R. .
BRITISH JOURNAL OF CANCER, 2012, 106 (05) :939-946
[25]   Exosomes as novel biomarkers in anticancer therapy [J].
Senfter D. ;
Mader R.M. .
memo - Magazine of European Medical Oncology, 2015, 8 (4) :231-234
[26]   Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection [J].
Takahashi, Yuki ;
Nishikawa, Makiya ;
Shinotsuka, Haruka ;
Matsui, Yuriko ;
Ohara, Saori ;
Imai, Takafumi ;
Takakura, Yoshinobu .
JOURNAL OF BIOTECHNOLOGY, 2013, 165 (02) :77-84
[27]   Circulating DNA and DNase activity in human blood [J].
Tamkovich, Svetlana N. ;
Cherepanova, Anna V. ;
Kolesnikova, Elena V. ;
Rykova, Elena Y. ;
Pyshnyi, Dmitrii V. ;
Vlassov, Valentin V. ;
Laktionov, Pavel P. .
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM IV, 2006, 1075 :191-196
[28]   CANCER Diagnosis by extracellular vesicles [J].
Thery, Clotilde .
NATURE, 2015, 523 (7559) :161-162
[29]   The clinical potential of Enhanced-ice-COLD-PCR [J].
Tost, Joerg .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (03) :265-268
[30]   Disseminated Tumor Cells in Bone Marrow and the Natural Course of Resected Esophageal Cancer [J].
Vashist, Yogesh K. ;
Effenberger, Katharina E. ;
Vettorazzi, Eik ;
Riethdorf, Sabine ;
Yekebas, Emre F. ;
Izbicki, Jakob R. ;
Pantel, Klaus .
ANNALS OF SURGERY, 2012, 255 (06) :1105-1112
1234